Myasthaenia Gravis Clinical Trials
3 recruiting trials for Myasthaenia Gravis. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
2
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT06617741
Myasthenia Gravis Foundation of America Global MG Patient Registry
The goal of this observational study is to learn about the experiences of people living with Myasthenia Gravis (MG) in the United States. The main questions it aims to answer are:...
Sponsor: Myasthenia Gravis Foundation of AmericaEnrolling: 38001 location
RECRUITINGPhase 3NCT06765161
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
This study is an open label, single center, prospective, 26 weeks study with descriptive analysis where IVIG is replaced by efgartigimod therapy. MG-ADL and MGQOL evaluations will...
Sponsor: Clinique Neuro-OutaouaisEnrolling: 301 location
RECRUITINGPhase 3NCT06799247
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
The AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylcholine receptor...
Sponsor: Cartesian TherapeuticsEnrolling: 10020 locations